Rachel King - Insider Trading & Ownership

Location
C/O Glycomimetics, Inc., 401 Professional Drive, Suite 250, Gaithersburg, MD
Summary
The estimated net worth of Rachel King is at least $2.03M dollars as of June 30, 2025. Rachel King is the Director of GLYCOMIMETICS INC and owns shares of GLYCOMIMETICS INC (GLYC) stock worth about $1.55M. Rachel King is the Director of NOVAVAX INC and owns shares of NOVAVAX INC (NVAX) stock worth about $483K.
Signature
/s/ Alan Musso, as attorney-in-fact for Rachel King
All Insider Reports
All Insider Reports

Ownership of Rachel King

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
GLYC GLYCOMIMETICS INC Director $1.55M May 1, 2024
NVAX NOVAVAX INC Director $483K -$37.4K -7.2% Jun 20, 2025
FULC Fulcrum Therapeutics, Inc. Director Jun 26, 2025

Insider Transactions Reported by Rachel King:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.